Covering all the bases: Preclinical development of an effective Staphylococcus aureus vaccine

A key aspect of the pathogenesis of the Gram positive bacterium Staphylococcus aureus is its ability to rapidly adapt to the host environment during the course of an infection. To successfully establish infection, the organism deploys a variety of survival and immune evasion strategies, ranging fro...

Full description

Bibliographic Details
Main Authors: Ingrid L Scully, Paul A Liberator, Kathrin U Jansen, Annaliesa S Anderson
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00109/full
_version_ 1811303500319031296
author Ingrid L Scully
Paul A Liberator
Kathrin U Jansen
Annaliesa S Anderson
author_facet Ingrid L Scully
Paul A Liberator
Kathrin U Jansen
Annaliesa S Anderson
author_sort Ingrid L Scully
collection DOAJ
description A key aspect of the pathogenesis of the Gram positive bacterium Staphylococcus aureus is its ability to rapidly adapt to the host environment during the course of an infection. To successfully establish infection, the organism deploys a variety of survival and immune evasion strategies, ranging from the acquisition of essential nutrients and expression of adhesins, which promote colonization and survival, to the elaboration of virulence factors such as capsule, which aids host immune evasion. The ability of S. aureus to deploy different virulence factors must be taken into account for S. aureus vaccine design. Here we present a strategy for designing an effective vaccine against S. aureus disease by evaluating vaccine candidate performance in multiple in vivo models targeted to mimic aspects of human disease, and by co-development of functional in vitro immunoassays that measure the neutralization of relevant S. aureus virulence factors.
first_indexed 2024-04-13T07:49:01Z
format Article
id doaj.art-6cafeaa4fb6a470d856e6490015db056
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-13T07:49:01Z
publishDate 2014-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-6cafeaa4fb6a470d856e6490015db0562022-12-22T02:55:35ZengFrontiers Media S.A.Frontiers in Immunology1664-32242014-03-01510.3389/fimmu.2014.0010982957Covering all the bases: Preclinical development of an effective Staphylococcus aureus vaccineIngrid L Scully0Paul A Liberator1Kathrin U Jansen2Annaliesa S Anderson3Pfizer Vaccine Research and Development UnitPfizer Vaccine Research and Development UnitPfizer Vaccine Research and Development UnitPfizer Vaccine Research and Development UnitA key aspect of the pathogenesis of the Gram positive bacterium Staphylococcus aureus is its ability to rapidly adapt to the host environment during the course of an infection. To successfully establish infection, the organism deploys a variety of survival and immune evasion strategies, ranging from the acquisition of essential nutrients and expression of adhesins, which promote colonization and survival, to the elaboration of virulence factors such as capsule, which aids host immune evasion. The ability of S. aureus to deploy different virulence factors must be taken into account for S. aureus vaccine design. Here we present a strategy for designing an effective vaccine against S. aureus disease by evaluating vaccine candidate performance in multiple in vivo models targeted to mimic aspects of human disease, and by co-development of functional in vitro immunoassays that measure the neutralization of relevant S. aureus virulence factors.http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00109/fullStaphylococcus aureusVaccineimmunoassayspreclinical modelsClumping factor Acapsular polysaccharide conjugates
spellingShingle Ingrid L Scully
Paul A Liberator
Kathrin U Jansen
Annaliesa S Anderson
Covering all the bases: Preclinical development of an effective Staphylococcus aureus vaccine
Frontiers in Immunology
Staphylococcus aureus
Vaccine
immunoassays
preclinical models
Clumping factor A
capsular polysaccharide conjugates
title Covering all the bases: Preclinical development of an effective Staphylococcus aureus vaccine
title_full Covering all the bases: Preclinical development of an effective Staphylococcus aureus vaccine
title_fullStr Covering all the bases: Preclinical development of an effective Staphylococcus aureus vaccine
title_full_unstemmed Covering all the bases: Preclinical development of an effective Staphylococcus aureus vaccine
title_short Covering all the bases: Preclinical development of an effective Staphylococcus aureus vaccine
title_sort covering all the bases preclinical development of an effective staphylococcus aureus vaccine
topic Staphylococcus aureus
Vaccine
immunoassays
preclinical models
Clumping factor A
capsular polysaccharide conjugates
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00109/full
work_keys_str_mv AT ingridlscully coveringallthebasespreclinicaldevelopmentofaneffectivestaphylococcusaureusvaccine
AT paulaliberator coveringallthebasespreclinicaldevelopmentofaneffectivestaphylococcusaureusvaccine
AT kathrinujansen coveringallthebasespreclinicaldevelopmentofaneffectivestaphylococcusaureusvaccine
AT annaliesasanderson coveringallthebasespreclinicaldevelopmentofaneffectivestaphylococcusaureusvaccine